Skip to content

The Effect of a Psychotherapy Protocol on Dream Awareness in Adults With Generalized Anxiety Disorder.

Siamak Khodarahimi, Fazlolah Mirderikvand, Kourosh Amraei

The Journal of Nervous and Mental Disease April 1, 2021 DOI: 10.1097/nmd.0000000000001292 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized clinical trial Peer reviewed
Sample size 60
Population Self-referred male and female adults with generalized anxiety disorder
Intervention Affective and Sensory Psychotherapy Protocol (ASPP)
Duration 3-month follow-up
Topics Anxiety
Key findings The Affective and Sensory Psychotherapy Protocol significantly increased dream recall, attitude toward dreams, and total dream score in adults with generalized anxiety disorder compared to a control group.

Abstract

This study aimed to examine the effect of an Affective and Sensory Psychotherapy Protocol (ASPP) on dream awareness in adults with generalized anxiety disorder (GAD). For this purpose, 60 self-referred male and female adults were studied within a randomized clinical trial. The Generalized Anxiety Disorder 7-Item Scale and the Mannheim Dream Questionnaire were used at baseline, posttreatment, and 3-month follow-up. No significant difference was observed between patients in the experimental and control groups at baseline. Findings showed that patients in the experimental group had a significant increase in dream recall, attitude toward dreams, and the total dream score than individuals in the control group. However, no sex difference was observed in the results for within-subject and between-group effects in the current study. The present research supported the influence of an ASPP on dream awareness in adults with GAD.

Comparable studies

Other randomized controlled trials on anxiety, most cited first.

Study Year Design Participants
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Hallucinogen-naïve adults reporting regular participation in religious or spiritual... 2006 Double-blind study n = 36
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Adults with advanced-stage cancer and anxiety 2010 Double-blind, placebo-controlled study n = 12

Citations in the library

Explore topics